NAMA
GH icon

Nikko Asset Management Americas’s Guardant Health GH Stock Holding History

Nikko Asset Management Americas’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.5M Sell
403,817
-79,740
-16% -$8.67M 0.78% 36
2026
Q1 		$44.6M Sell
483,557
-156,738
-24% -$15.7M 0.63% 42
2025
Q4 		$65.4M Sell
640,295
-113,649
-15% -$10.2M 0.76% 40
2025
Q3 		$47.1M Sell
753,944
-1,276,484
-63% -$69.4M 0.46% 52
2025
Q2 		$106M Buy
2,030,428
+673,438
+50% +$30.1M 1.05% 25
2025
Q1 		$57.8M Sell
1,356,990
-107,223
-7% -$4.63M 0.74% 33
2024
Q4 		$44.7M Buy
1,464,213
+197,729
+16% +$5.56M 0.48% 47
2024
Q3 		$29.1M Buy
1,266,484
+1,177,790
+1,328% +$33.3M 0.33% 57
2024
Q2 		$2.56M Buy
88,694
+4,648
+6% +$108K 0.03% 125
2024
Q1 		$1.73M Sell
84,046
-9,699
-10% -$208K 0.02% 141
2023
Q4 		$2.54M Sell
93,745
-18,096
-16% -$475K 0.02% 134
2023
Q3 		$3.31M Sell
111,841
-102
-0.1% -$3.59K 0.04% 124
2023
Q2 		$4M Buy
111,943
+3,745
+3% +$108K 0.04% 121
2023
Q1 		$2.53M Buy
108,198
+29,886
+38% +$854K 0.03% 138
2022
Q4 		$2.13M Sell
78,312
-5,903
-7% -$270K 0.03% 150
2022
Q3 		$4.04M Buy
+84,215
New +$4.32M 0.05% 119
2021
Q2 		– Sell
-148,614
Closed -$22.7M – 213
2021
Q1 		$22.7M Buy
148,614
+15,966
+12% +$2.41M 0.11% 99
2020
Q4 		$17.1M Sell
132,648
-11,446
-8% -$1.32M 0.1% 105
2020
Q3 		$16.1M Sell
144,094
-117,628
-45% -$10.8M 0.14% 93
2020
Q2 		$20.6M Sell
261,722
-124,590
-32% -$10M 0.27% 60
2020
Q1 		$26.9M Buy
386,312
+10,005
+3% +$768K 0.5% 53
2019
Q4 		$29.4M Buy
376,307
+65,788
+21% +$4.74M 0.46% 58
2019
Q3 		$19.8M Buy
310,519
+100,088
+48% +$8.82M 0.35% 62
2019
Q2 		$18.2M Buy
+210,431
New +$16.1M 0.36% 65

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nikko Asset Management Americas's GH Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Guardant Health (GH) stake by 16% in Q2 2026, selling an estimated $8.67M and leaving 403,817 shares worth $60.5M. The position accounts for 0.78% of the portfolio, ranked #36.

Nikko Asset Management Americas first reported a position in GH in Q2 2019 and has held it in 24 quarters since. The position peaked at $106M in Q2 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Nikko Asset Management Americas held 403,817 shares of Guardant Health worth $60.5M as of Q2 2026.
  • Nikko Asset Management Americas sold 79,740 Guardant Health shares in Q2 2026, an estimated $8.67M.
  • Guardant Health made up 0.78% of Nikko Asset Management Americas's portfolio in Q2 2026, its #36 holding.
  • Nikko Asset Management Americas first reported a position in Guardant Health in Q2 2019 and has held it in 24 quarters since.
  • Nikko Asset Management Americas's Guardant Health position peaked at $106M in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.